The hypothesis is that vitamin C is well tolerated and increases cancer treatment effectiveness, lengthening survival time for patients with advanced pancreatic cancer. Detailed Description:. Though ascorbate has been utilized in cancer therapy, few studies have investigated intravenous deliver of ascorbate.
Subsequent well-designed, randomized, controlled trials of vitamin C and cancer found no such treatment benefit. Despite the lack of evidence, alternative .
Early clinical studies showed that high-dose vitamin C, given by intravenous and oral routes, may improve symptoms and prolong life in patients with terminal .
This article reviews intravenous vitamin C (IV C) in cancer care and offers a. Phase i trials in which IV C doses of 75â€“220 g (up to 1.5 g/kg or 110 mg/m2) were